{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:09:21Z","timestamp":1777392561484,"version":"3.51.4"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-03943-5","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:46:30Z","timestamp":1773845190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The nature of depression and the biomedical model: ten questions in search of an answer"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-0811","authenticated-orcid":false,"given":"Konstantinos N.","family":"Fountoulakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"3943_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1503\/cmaj.070693","volume":"178","author":"C Barbui","year":"2008","unstructured":"Barbui C, Furukawa TA, Cipriani A. Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. CMAJ. 2008;178:296\u2013305. https:\/\/doi.org\/10.1503\/cmaj.070693.","journal-title":"CMAJ"},{"key":"3943_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.2009.1943","volume":"303","author":"JC Fournier","year":"2010","unstructured":"Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303:47\u201353. https:\/\/doi.org\/10.1001\/jama.2009.1943.","journal-title":"JAMA"},{"key":"3943_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/j.1399-5618.2008.00639.x","volume":"10","author":"SN Ghaemi","year":"2008","unstructured":"Ghaemi SN. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression. Bipolar Disord. 2008;10:957\u201368. https:\/\/doi.org\/10.1111\/j.1399-5618.2008.00639.x.","journal-title":"Bipolar Disord"},{"key":"3943_CR4","doi-asserted-by":"publisher","first-page":"CD003012","DOI":"10.1002\/14651858.CD003012.pub2","volume":"2004","author":"J Moncrieff","year":"2004","unstructured":"Moncrieff J, Wessely S, Hardy R. Active placebos versus antidepressants for depression. Cochrane Database Syst Rev. 2004;2004:CD003012. https:\/\/doi.org\/10.1002\/14651858.CD003012.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"3943_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMsa065779","volume":"358","author":"EH Turner","year":"2008","unstructured":"Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252\u201360. https:\/\/doi.org\/10.1056\/NEJMsa065779.","journal-title":"N Engl J Med"},{"key":"3943_CR6","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","volume":"28","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2023;28:3243\u201356. https:\/\/doi.org\/10.1038\/s41380-022-01661-0.","journal-title":"Mol Psychiatry"},{"key":"3943_CR7","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1038\/s41380-023-02094-z","volume":"28","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Ploderl M, Horowitz MA. The serotonin hypothesis of depression: both long discarded and still supported?. Mol Psychiatry. 2023;28:3160\u20133. https:\/\/doi.org\/10.1038\/s41380-023-02094-z.","journal-title":"Mol Psychiatry"},{"key":"3943_CR8","unstructured":"Angell M. The Epidemic of Mental Illness: Why?, http:\/\/www.nybooks.com\/articles\/archives\/2011\/jun\/23\/epidemic-mental-illness-why\/?pagination=false (2011)."},{"key":"3943_CR9","unstructured":"Angell M. The Illusions of Psychiatry. 2011. http:\/\/www.nybooks.com\/articles\/archives\/2011\/jul\/14\/illusions-of-psychiatry\/?pagination=false"},{"key":"3943_CR10","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","volume":"5","author":"I Kirsch","year":"2008","unstructured":"Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5:e45 https:\/\/doi.org\/10.1371\/journal.pmed.0050045.","journal-title":"PLoS Med"},{"key":"3943_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1017\/s1121189x00000282","volume":"18","author":"I Kirsch","year":"2009","unstructured":"Kirsch I. Antidepressants and the placebo response. Epidemiol Psichiatr Soc. 2009;18:318\u201322. https:\/\/doi.org\/10.1017\/s1121189x00000282.","journal-title":"Epidemiol Psichiatr Soc"},{"key":"3943_CR12","volume-title":"The Emperor\u2019s New Drugs: Exploding the Antidepressant Myth","author":"I Kirsch","year":"2009","unstructured":"Kirsch I. The Emperor\u2019s New Drugs: Exploding the Antidepressant Myth. London: The Bodley Head; 2009."},{"key":"3943_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00406-021-01272-w","volume":"271","author":"KN Fountoulakis","year":"2021","unstructured":"Fountoulakis KN. Should denialism of mental illness and its treatment be included among conspiracy theories?. Eur Arch Psychiatry Clin Neurosci. 2021;271:591\u20133. https:\/\/doi.org\/10.1007\/s00406-021-01272-w.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3943_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10654-016-0149-3","volume":"31","author":"S Greenland","year":"2016","unstructured":"Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31:337\u201350. https:\/\/doi.org\/10.1007\/s10654-016-0149-3.","journal-title":"Eur J Epidemiol"},{"key":"3943_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-20","volume":"9","author":"MB Westover","year":"2011","unstructured":"Westover MB, Westover KD, Bianchi MT. Significance testing as perverse probabilistic reasoning. BMC Med. 2011;9:20. https:\/\/doi.org\/10.1186\/1741-7015-9-20.","journal-title":"BMC Med"},{"key":"3943_CR16","unstructured":"Fountoulakis, KN in Psychiatry (ed Konstantinos N. Fountoulakis) Ch. Chapter 10, 171\u2013236 (Springer International Publishing, 2022)."},{"key":"3943_CR17","unstructured":"Fountoulakis, KN in Psychiatry (ed Konstantinos N. Fountoulakis) Ch. Chapter 11, 237\u2013326 (Springer International Publishing, 2022)."},{"key":"3943_CR18","unstructured":"Fountoulakis, KN in Psychiatry (ed Konstantinos N. Fountoulakis) Ch. Chapter 22, 503\u201322 (Springer International Publishing, 2022)."},{"key":"3943_CR19","unstructured":"Fountoulakis, KN in Psychiatry (ed Konstantinos N. Fountoulakis) Ch. Chapter 23, 523\u201334 (Springer International Publishing, 2022)."},{"key":"3943_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0033291712003030","volume":"44","author":"KS Kendler","year":"2014","unstructured":"Kendler KS, Campbell J. Expanding the domain of the understandable in psychiatric illness: An updating of the Jasperian framework of explanation and understanding. Psychological medicine. 2014;44:1\u20137. https:\/\/doi.org\/10.1017\/S0033291712003030.","journal-title":"Psychological medicine"},{"key":"3943_CR21","unstructured":"Bolton D, Hill J. Mind, meaning, and mental disorder: The nature of causal explanation in psychology and psychiatry (Oxford University Press, 1996)."},{"key":"3943_CR22","doi-asserted-by":"crossref","unstructured":"Fulford KWM, Thornton T, Graham G (eds). Karl Jaspers and General Psychopathology. In: The Oxford Textbook of Philosophy and Psychiatry, Ch. 8, 160\u2013179 (Oxford University Press, 2006).","DOI":"10.1093\/oso\/9780198526940.003.0008"},{"key":"3943_CR23","unstructured":"Fountoulakis KN in Psychiatry (ed Konstantinos N. Fountoulakis) Ch. Chapter 13, 333-83 (Springer International Publishing, 2022)."},{"key":"3943_CR24","unstructured":"Kendler K & Parnas, J (Oxford University Press, 2013)."},{"key":"3943_CR25","unstructured":"Kendler K & Parnas, J (Oxford University Press, 2015)."},{"key":"3943_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jad.2012.08.038","volume":"146","author":"AF Carvalho","year":"2013","unstructured":"Carvalho AF, Hyphantis TN, Taunay TC, Macedo DS, Floros GD, Ottoni GL, et al. The relationship between affective temperaments, defensive styles and depressive symptoms in a large sample. Journal of affective disorders. 2013;146:58\u201365. https:\/\/doi.org\/10.1016\/j.jad.2012.08.038.","journal-title":"Journal of affective disorders"},{"key":"3943_CR27","doi-asserted-by":"crossref","unstructured":"Eysenck HJ in Handbook of Abnormal Psychology (ed HJ Eysenck) (Pitman Medical Publishing Company Ltd., 1960).","DOI":"10.1097\/00000441-196111000-00034"},{"key":"3943_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2307\/2094300","volume":"39","author":"TJ Scheff","year":"1974","unstructured":"Scheff TJ. The labelling theory of mental illness. Am Sociol Rev. 1974;39:444\u201352.","journal-title":"Am Sociol Rev"},{"key":"3943_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2307\/3527464","volume":"1","author":"P Sedgwick","year":"1973","unstructured":"Sedgwick P. Illness\u2013mental and otherwise. Stud Hastings Cent. 1973;1:19\u201340.","journal-title":"Stud Hastings Cent"},{"key":"3943_CR30","volume-title":"Histoire de la folie \u00e0 l\u2019\u00e2ge classique","author":"M Foucault","year":"1961","unstructured":"Foucault M Histoire de la folie \u00e0 l\u2019\u00e2ge classique. Paris: Plon; 1961."},{"key":"3943_CR31","unstructured":"Foucault M Madness and Civilization: A History of Insanity in the Age of Reason. (Vintage, 1988)."},{"key":"3943_CR32","doi-asserted-by":"publisher","DOI":"10.4324\/9780203278796","volume-title":"Madness and Civilization","author":"M Foucault","year":"1961","unstructured":"Foucault M, Howard R, Cooper D Madness and Civilization. Taylor & Francis; 1961."},{"key":"3943_CR33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/bmj.2.6193.757","volume":"2","author":"EJ Campbell","year":"1979","unstructured":"Campbell EJ, Scadding JG, Roberts RS. The concept of disease. Br Med J. 1979;2:757\u201362. https:\/\/doi.org\/10.1136\/bmj.2.6193.757.","journal-title":"Br Med J"},{"key":"3943_CR34","volume-title":"The Politics of Experience","author":"R Laing","year":"1967","unstructured":"Laing R The Politics of Experience. Harmondsworth: Penguin Books; 1967."},{"key":"3943_CR35","volume-title":"The Myth of Mental Illness: Foundations of a Theory of Personal Conduct","author":"T Szasz","year":"1961","unstructured":"Szasz T The Myth of Mental Illness: Foundations of a Theory of Personal Conduct. New York: Hober-Harper; 1961."},{"key":"3943_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-017738-0.50007-7","volume-title":"The Myth of Mental Illness","author":"TS Szasz","year":"1974","unstructured":"Szasz TS The Myth of Mental Illness. New York: Harper and Row; 1974."},{"key":"3943_CR37","doi-asserted-by":"publisher","first-page":"e067606","DOI":"10.1136\/bmj-2021-067606","volume":"378","author":"MB Stone","year":"2022","unstructured":"Stone MB, Yaseen ZS, Miller BJ, Richardville K, Kalaria SN, Kirsch I. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis. BMJ. 2022;378:e067606. https:\/\/doi.org\/10.1136\/bmj-2021-067606.","journal-title":"BMJ"},{"key":"3943_CR38","doi-asserted-by":"publisher","first-page":"k2234","DOI":"10.1136\/bmj.k2234","volume":"361","author":"NG Forouhi","year":"2018","unstructured":"Forouhi NG, Misra A, Mohan V, Taylor R, Yancy W. Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ. 2018;361:k2234 https:\/\/doi.org\/10.1136\/bmj.k2234.","journal-title":"BMJ"},{"key":"3943_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBDD Collaborators","year":"2023","unstructured":"Collaborators GBDD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.","journal-title":"Lancet"},{"key":"3943_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.psychres.2005.09.018","volume":"143","author":"KN Fountoulakis","year":"2006","unstructured":"Fountoulakis KN, Iacovides A, Kaprinis S, Kaprinis G. Life events and clinical subtypes of major depression: A cross-sectional study. Psychiatry Res. 2006;143:235\u201344. https:\/\/doi.org\/10.1016\/j.psychres.2005.09.018.","journal-title":"Psychiatry Res"},{"key":"3943_CR41","doi-asserted-by":"crossref","unstructured":"Fountoulakis, KN in Bipolar Disorder (ed Kostas N. Fountoulakis) Ch. Chapter 1, 1-25 (Springer Berlin Heidelberg, 2015).","DOI":"10.1007\/978-3-642-37216-2_1"},{"key":"3943_CR42","unstructured":"Fountoulakis, KN in Psychiatry (ed Konstantinos N. Fountoulakis) Ch. Chapter 3, 15-43 (Springer International Publishing, 2022)."},{"key":"3943_CR43","unstructured":"Fountoulakis, KN in Psychiatry (ed Konstantinos N. Fountoulakis) Ch. Chapter 9, 127-69 (Springer International Publishing, 2022)."},{"key":"3943_CR44","unstructured":"Leoni F in The Oxford Handbook of Philosophy and Psychiatry (eds KWM Fulford et al.) (Oxford University Press, 2013)."},{"key":"3943_CR45","volume-title":"The Oxford Dictionary of Philosophy","author":"S Blackburn","year":"2008","unstructured":"Blackburn S The Oxford Dictionary of Philosophy. Oxford University Press; 2008."},{"key":"3943_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199919758.001.0001","volume-title":"Mind and Cosmos: Why the Materialist Neo-Darwinian Conception of Nature is Almost Certainly False","author":"T Nagel","year":"2012","unstructured":"Nagel T Mind and Cosmos: Why the Materialist Neo-Darwinian Conception of Nature is Almost Certainly False. Oxford University Press; 2012."},{"key":"3943_CR47","volume-title":"Aspects of scientific explanation","author":"C Hempel","year":"1965","unstructured":"Hempel C Aspects of scientific explanation. Free Press; 1965."},{"key":"3943_CR48","doi-asserted-by":"publisher","DOI":"10.1119\/1.1937571","volume-title":"The structure of science","author":"E Nagel","year":"1961","unstructured":"Nagel E The structure of science. New York: Harcourt, Brace, and World; 1961."},{"key":"3943_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1023\/a:1004949814965","volume":"111","author":"ER Scerri","year":"1997","unstructured":"Scerri ER, McIntyre LEE. THE CASE FOR THE PHILOSOPHY OF CHEMISTRY. Synthese. 1997;111:213\u201332. https:\/\/doi.org\/10.1023\/a:1004949814965.","journal-title":"Synthese"},{"key":"3943_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02698590701305735","volume":"21","author":"M Esfeld","year":"2007","unstructured":"Esfeld M, Sachse C. Theory Reduction by Means of Functional Sub-types. International Studies in the Philosophy of Science. 2007;21:1\u201317. https:\/\/doi.org\/10.1080\/02698590701305735.","journal-title":"International Studies in the Philosophy of Science"},{"key":"3943_CR51","unstructured":"Campbell DT in Studies in the philosophy of biology (eds FJ Ayala & T Dobzhansky) 179-86 (University of California Press, 1974)."},{"key":"3943_CR52","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1080\/00048402.2014.992447","volume":"93","author":"J Schaffer","year":"2015","unstructured":"Schaffer J. What Not to Multiply Without Necessity. Australasian Journal of Philosophy. 2015;93:644\u201364.","journal-title":"Australasian Journal of Philosophy"},{"key":"3943_CR53","volume-title":"Ockham\u2019s Razor: A Historical and Philosophical Analysis of Ockham\u2019s Principle of Parsimony","author":"R Ariew","year":"1976","unstructured":"Ariew R Ockham\u2019s Razor: A Historical and Philosophical Analysis of Ockham\u2019s Principle of Parsimony. Urbana-Champaign: University of Illnois at Urbana-Champaign; 1976."},{"key":"3943_CR54","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1037\/h0028156","volume":"76","author":"RW Sperry","year":"1969","unstructured":"Sperry RW. A modified concept of consciousness. Psychol Rev. 1969;76:532\u20136. https:\/\/doi.org\/10.1037\/h0028156.","journal-title":"Psychol Rev"},{"key":"3943_CR55","unstructured":"Van Gulick, R in Mental causation (eds J Heil & A Mele) 233\u2013256 (Clarendon Press, 1995)."},{"key":"3943_CR56","volume-title":"Downward Causation: Minds, Bodies and Matter","author":"P Andersen","year":"2001","unstructured":"Andersen P, Emmeche C, Finnemann N, Christiansen P Downward Causation: Minds, Bodies and Matter. Aarchus: Aarhus University Press; 2001."},{"key":"3943_CR57","unstructured":"Haken H & Stadler, M (Springer, Berlin, New York, Heidelberg, 1990)."},{"key":"3943_CR58","volume-title":"Principles of brain functioning","author":"H Haken","year":"1995","unstructured":"Haken H Principles of brain functioning. Berlin, New York: Springer; 1995."},{"key":"3943_CR59","first-page":"642","volume":"7","author":"A Stephan","year":"1996","unstructured":"Stephan A. Ordner, Sklaven and andere Systemgeister [Orderlies, slaves and other ghosts in the system]. Ethik and Sozialwissenschaften. 1996;7:642\u20133.","journal-title":"Ethik and Sozialwissenschaften"},{"key":"3943_CR60","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1017\/S1092852924000026","volume":"29","author":"KN Fountoulakis","year":"2024","unstructured":"Fountoulakis KN, Karakatsoulis GN, Abraham S, Adorjan K, Ahmed HU, Alarcon RD, et al. Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study). CNS Spectr. 2024;29:126\u201349. https:\/\/doi.org\/10.1017\/S1092852924000026.","journal-title":"CNS Spectr"},{"key":"3943_CR61","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/mp.2009.44","volume":"14","author":"J Belsky","year":"2009","unstructured":"Belsky J, Jonassaint C, Pluess M, Stanton M, Brummett B, Williams R. Vulnerability genes or plasticity genes?. Mol Psychiatry. 2009;14:746\u201354. https:\/\/doi.org\/10.1038\/mp.2009.44.","journal-title":"Mol Psychiatry"},{"key":"3943_CR62","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1469-7610.2005.01557.x","volume":"47","author":"M Rutter","year":"2006","unstructured":"Rutter M, Moffitt TE, Caspi A. Gene-environment interplay and psychopathology: multiple varieties but real effects. J Child Psychol Psychiatry. 2006;47:226\u201361. https:\/\/doi.org\/10.1111\/j.1469-7610.2005.01557.x.","journal-title":"J Child Psychol Psychiatry"},{"key":"3943_CR63","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nrd1303","volume":"3","author":"ML Wong","year":"2004","unstructured":"Wong ML, Licinio J. From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov. 2004;3:136\u201351. https:\/\/doi.org\/10.1038\/nrd1303.","journal-title":"Nat Rev Drug Discov"},{"key":"3943_CR64","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/35072566","volume":"2","author":"ML Wong","year":"2001","unstructured":"Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci. 2001;2:343\u201351. https:\/\/doi.org\/10.1038\/35072566.","journal-title":"Nat Rev Neurosci"},{"key":"3943_CR65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/schbul\/sbm105","volume":"34","author":"A Cohen","year":"2008","unstructured":"Cohen A, Patel V, Thara R, Gureje O. Questioning an axiom: better prognosis for schizophrenia in the developing world?. Schizophr Bull. 2008;34:229\u201344. https:\/\/doi.org\/10.1093\/schbul\/sbm105.","journal-title":"Schizophr Bull"},{"key":"3943_CR66","doi-asserted-by":"publisher","first-page":"259","DOI":"10.22365\/jpsych.2017.283.259","volume":"28","author":"KN Fountoulakis","year":"2017","unstructured":"Fountoulakis KN. Employment insecurity, mental health and suicide. Psychiatriki. 2017;28:259\u201364. https:\/\/doi.org\/10.22365\/jpsych.2017.283.259.","journal-title":"Psychiatriki"},{"key":"3943_CR67","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jad.2019.09.001","volume":"260","author":"KN Fountoulakis","year":"2020","unstructured":"Fountoulakis KN. Suicides in Greece before and during the period of austerity by sex and age group: Relationship to unemployment and economic variables. Journal of affective disorders. 2020;260:174\u201382. https:\/\/doi.org\/10.1016\/j.jad.2019.09.001.","journal-title":"Journal of affective disorders"},{"key":"3943_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-016-0106-2","volume":"15","author":"KN Fountoulakis","year":"2016","unstructured":"Fountoulakis KN, Chatzikosta I, Pastiadis K, Zanis P, Kawohl W, Kerkhof AJ, et al. Relationship of suicide rates with climate and economic variables in Europe during 2000-2012. Ann Gen Psychiatry. 2016;15:19. https:\/\/doi.org\/10.1186\/s12991-016-0106-2.","journal-title":"Ann Gen Psychiatry"},{"key":"3943_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.114378","volume":"309","author":"KN Fountoulakis","year":"2022","unstructured":"Fountoulakis KN, Fountoulakis NK. Climate rather than economic variables might have caused increase in US homicide but not suicide rates during the Great Depression. Psychiatry Res. 2022;309:114378. https:\/\/doi.org\/10.1016\/j.psychres.2021.114378.","journal-title":"Psychiatry Res"},{"key":"3943_CR70","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.psychres.2016.12.059","volume":"249","author":"KN Fountoulakis","year":"2017","unstructured":"Fountoulakis KN, Gonda X. Differential correlation of suicide and homicide rates according to geographical areas: A study with population-level data. Psychiatry Res. 2017;249:167\u201371. https:\/\/doi.org\/10.1016\/j.psychres.2016.12.059.","journal-title":"Psychiatry Res"},{"key":"3943_CR71","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jad.2018.02.030","volume":"232","author":"KN Fountoulakis","year":"2018","unstructured":"Fountoulakis KN, Gonda X. Ancestry and different rates of suicide and homicide in European countries: A study with population-level data. J Affect Disord. 2018;232:152\u201362. https:\/\/doi.org\/10.1016\/j.jad.2018.02.030.","journal-title":"J Affect Disord"},{"key":"3943_CR72","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00127-023-02438-8","volume":"58","author":"K N Fountoulakis","year":"2023","unstructured":"N Fountoulakis K, N Karakatsoulis G, Abraham S, Adorjan K, Ahmed HU, Alarcon RD, et al. Results of the COVID-19 mental health international for the health professionals (COMET-HP) study: depression, suicidal tendencies and conspiracism. Soc Psychiatry Psychiatr Epidemiol. 2023;58:1387\u2013410. https:\/\/doi.org\/10.1007\/s00127-023-02438-8.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"3943_CR73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/acps.13284","volume":"143","author":"KN Fountoulakis","year":"2021","unstructured":"Fountoulakis KN. Being strictly scientific is the only way forward for psychiatry. Acta Psychiatr Scand. 2021;143:187\u20138. https:\/\/doi.org\/10.1111\/acps.13284.","journal-title":"Acta Psychiatr Scand"},{"key":"3943_CR74","volume-title":"The Logic of Scientific Discovery","author":"K Popper","year":"1959","unstructured":"Popper K The Logic of Scientific Discovery. New York: Basic Books; 1959."},{"key":"3943_CR75","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/0269881113504014","volume":"28","author":"KN Fountoulakis","year":"2014","unstructured":"Fountoulakis KN, Samara MT, Siamouli M. Burning issues in the meta-analysis of pharmaceutical trials for depression. J Psychopharmacol. 2014;28:106\u201317. https:\/\/doi.org\/10.1177\/0269881113504014.","journal-title":"J Psychopharmacol"},{"key":"3943_CR76","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/bmj.39510.531597.80","volume":"336","author":"EH Turner","year":"2008","unstructured":"Turner EH, Rosenthal R. Efficacy of antidepressants. BMJ. 2008;336:516\u20137. https:\/\/doi.org\/10.1136\/bmj.39510.531597.80.","journal-title":"BMJ"},{"key":"3943_CR77","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1192\/bjp.176.5.421","volume":"176","author":"P Bech","year":"2000","unstructured":"Bech P, Cialdella P, Haugh MC, Birkett MA, Hours A, Boissel JP, Tollefson GD. Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression. Br J Psychiatry. 2000;176:421\u20138. https:\/\/doi.org\/10.1192\/bjp.176.5.421.","journal-title":"Br J Psychiatry"},{"key":"3943_CR78","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00004714-200202000-00007","volume":"22","author":"A Khan","year":"2002","unstructured":"Khan A, Leventhal RM, Khan SR, Brown WA. Severity of depression and response to antidepressants and placebo: An analysis of the Food and Drug Administration database. J Clin Psychopharmacol. 2002;22:40\u201345. https:\/\/doi.org\/10.1097\/00004714-200202000-00007.","journal-title":"J Clin Psychopharmacol"},{"key":"3943_CR79","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/npp.2011.306","volume":"37","author":"J Undurraga","year":"2012","unstructured":"Undurraga J, Baldessarini RJ. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology. 2012;37:851\u201364. https:\/\/doi.org\/10.1038\/npp.2011.306.","journal-title":"Neuropsychopharmacology"},{"key":"3943_CR80","doi-asserted-by":"publisher","first-page":"e024886","DOI":"10.1136\/bmjopen-2018-024886","volume":"9","author":"K Munkholm","year":"2019","unstructured":"Munkholm K, Paludan-Muller AS, Boesen K. Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis. BMJ Open. 2019;9:e024886. https:\/\/doi.org\/10.1136\/bmjopen-2018-024886.","journal-title":"BMJ Open"},{"key":"3943_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1173-2","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-Moller K, et al. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry. 2017;17:58. https:\/\/doi.org\/10.1186\/s12888-016-1173-2.","journal-title":"BMC Psychiatry"},{"key":"3943_CR82","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1192\/bjp.170.3.264","volume":"170","author":"RW Licht","year":"1997","unstructured":"Licht RW, Gouliaev G, Vestergaard P, Frydenberg M. Generalisability of results from randomised drug trials. A trial on antimanic treatment. Br J Psychiatry. 1997;170:264\u20137. https:\/\/doi.org\/10.1192\/bjp.170.3.264.","journal-title":"Br J Psychiatry"},{"key":"3943_CR83","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/hup.952","volume":"23","author":"A Talamo","year":"2008","unstructured":"Talamo A, Baldessarini RJ, Centorrino F. Comparison of mania patients suitable for treatment trials versus clinical treatment. Hum Psychopharmacol. 2008;23:447\u201354. https:\/\/doi.org\/10.1002\/hup.952.","journal-title":"Hum Psychopharmacol"},{"key":"3943_CR84","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/JCP.0b013e318058263f","volume":"27","author":"M Zetin","year":"2007","unstructured":"Zetin M, Hoepner CT. Relevance of exclusion criteria in antidepressant clinical trials: a replication study. J Clin Psychopharmacol. 2007;27:295\u2013301. https:\/\/doi.org\/10.1097\/JCP.0b013e318058263f.","journal-title":"J Clin Psychopharmacol"},{"key":"3943_CR85","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1176\/appi.ajp.159.3.469","volume":"159","author":"M Zimmerman","year":"2002","unstructured":"Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. Am J Psychiatry. 2002;159:469\u201373. https:\/\/doi.org\/10.1176\/appi.ajp.159.3.469.","journal-title":"Am J Psychiatry"},{"key":"3943_CR86","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4088\/jcp.v57n1203","volume":"57","author":"T Partonen","year":"1996","unstructured":"Partonen T, Sihvo S, Lonnqvist JK. Patients excluded from an antidepressant efficacy trial. J Clin Psychiatry. 1996;57:572\u20135. https:\/\/doi.org\/10.4088\/jcp.v57n1203.","journal-title":"J Clin Psychiatry"},{"key":"3943_CR87","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1176\/appi.ajp.2008.08071027","volume":"166","author":"SR Wisniewski","year":"2009","unstructured":"Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, et al. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry. 2009;166:599\u2013607. https:\/\/doi.org\/10.1176\/appi.ajp.2008.08071027.","journal-title":"Am J Psychiatry"},{"key":"3943_CR88","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1017\/S0033291710002175","volume":"41","author":"R van der Lem","year":"2011","unstructured":"van der Lem R, van der Wee NJ, van Veen T, Zitman FG. The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychological medicine. 2011;41:1353\u201363. https:\/\/doi.org\/10.1017\/S0033291710002175.","journal-title":"Psychological medicine"},{"key":"3943_CR89","doi-asserted-by":"publisher","first-page":"207","DOI":"10.31887\/DCNS.2006.8.2\/pbech","volume":"8","author":"P Bech","year":"2006","unstructured":"Bech P. Rating scales in depression: limitations and pitfalls. Dialogues Clin Neurosci. 2006;8:207\u201315. https:\/\/doi.org\/10.31887\/DCNS.2006.8.2\/pbech.","journal-title":"Dialogues Clin Neurosci"},{"key":"3943_CR90","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1600-0447.2011.01791.x","volume":"125","author":"P Bech","year":"2012","unstructured":"Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial. Acta Psychiatr Scand. 2012;125:342\u20138. https:\/\/doi.org\/10.1111\/j.1600-0447.2011.01791.x.","journal-title":"Acta Psychiatr Scand"},{"key":"3943_CR91","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jad.2011.03.011","volume":"132","author":"P Bech","year":"2011","unstructured":"Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ. Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets. J Affect Disord. 2011;132:396\u2013400. https:\/\/doi.org\/10.1016\/j.jad.2011.03.011.","journal-title":"J Affect Disord"},{"key":"3943_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-3-21","volume":"3","author":"KN Fountoulakis","year":"2003","unstructured":"Fountoulakis KN, Iacovides A, Kleanthous S, Samolis S, Gougoulias K, St Kaprinis G, Bech P. The Greek translation of the symptoms rating scale for depression and anxiety: preliminary results of the validation study. BMC Psychiatry. 2003;3:21. https:\/\/doi.org\/10.1186\/1471-244X-3-21.","journal-title":"BMC Psychiatry"},{"key":"3943_CR93","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","volume":"60","author":"M Tohen","year":"2003","unstructured":"Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60:1079\u201388. https:\/\/doi.org\/10.1001\/archpsyc.60.11.1079.","journal-title":"Arch Gen Psychiatry"},{"key":"3943_CR94","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41380-024-02458-z","volume":"29","author":"KN Fountoulakis","year":"2024","unstructured":"Fountoulakis KN, Tsapakis EM. Neither serotonin disorder is at the core of depression nor dopamine at the core of schizophrenia; still these are biologically based mental disorders. Mol Psychiatry. 2024;29:198\u20139. https:\/\/doi.org\/10.1038\/s41380-024-02458-z.","journal-title":"Mol Psychiatry"},{"key":"3943_CR95","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1371\/journal.pmed.0030190","volume":"3","author":"MS Milane","year":"2006","unstructured":"Milane MS, Suchard MA, Wong ML, Licinio J. Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States. PLoS Med. 2006;3:e190. https:\/\/doi.org\/10.1371\/journal.pmed.0030190.","journal-title":"PLoS Med"},{"key":"3943_CR96","volume-title":"The Truth About the Drug Companies: How They Deceive Us and What to Do About It","author":"M Angell","year":"2004","unstructured":"Angell M The Truth About the Drug Companies: How They Deceive Us and What to Do About It. Random House; 2004."},{"key":"3943_CR97","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry. 2006;163:1905\u201317. https:\/\/doi.org\/10.1176\/ajp.2006.163.11.1905.","journal-title":"Am J Psychiatry"},{"key":"3943_CR98","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1176\/ajp.2006.163.11.1864","volume":"163","author":"JC Nelson","year":"2006","unstructured":"Nelson JC. The STAR*D study: a four-course meal that leaves us wanting more. Am J Psychiatry. 2006;163:1864\u20136. https:\/\/doi.org\/10.1176\/ajp.2006.163.11.1864.","journal-title":"Am J Psychiatry"},{"key":"3943_CR99","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1176\/appi.ajp.20240515","volume":"182","author":"KN Fountoulakis","year":"2025","unstructured":"Fountoulakis KN, Saitis A, Schatzberg AF. Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis. Am J Psychiatry. 2025;182:259\u201375. https:\/\/doi.org\/10.1176\/appi.ajp.20240515.","journal-title":"Am J Psychiatry"},{"key":"3943_CR100","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-025-02897-1","author":"KN Fountoulakis","year":"2025","unstructured":"Fountoulakis KN, Tatsiopoulou P, Saitis A, Fountoulakis NK, Schatzberg AF. Ketamine\/esketamine treatment for resistant depression in children and adolescents: a PRISMA systematic review. Eur Child Adolesc Psychiatry. 2025. https:\/\/doi.org\/10.1007\/s00787-025-02897-1.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3943_CR101","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1176\/appi.ajp.20250745","volume":"182","author":"AF Schatzberg","year":"2025","unstructured":"Schatzberg AF, Fountoulakis KN. Esketamine 5 years after approval: Welcome new data with continuing questions. Am J Psychiatry. 2025;182:892\u20133. https:\/\/doi.org\/10.1176\/appi.ajp.20250745.","journal-title":"Am J Psychiatry"},{"key":"3943_CR102","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1176\/appi.ajp.20250551","volume":"182","author":"KN Fountoulakis","year":"2025","unstructured":"Fountoulakis KN, Saitis A, Schatzberg AF. Esketamine Treatment for Depression in Adults: Response to Price et al. and Canuso et al. Am J Psychiatry. 2025;182:954\u20136. https:\/\/doi.org\/10.1176\/appi.ajp.20250551.","journal-title":"Am J Psychiatry"},{"key":"3943_CR103","volume-title":"Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare","author":"P Gotzsche","year":"2013","unstructured":"Gotzsche P Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare. London: CRC Press; 2013."},{"key":"3943_CR104","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1017\/S1461145710000957","volume":"14","author":"KN Fountoulakis","year":"2011","unstructured":"Fountoulakis KN, Moller HJ. Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol. 2011;14:405\u201312. https:\/\/doi.org\/10.1017\/S1461145710000957.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3943_CR105","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/0269881110372544","volume":"25","author":"J Horder","year":"2011","unstructured":"Horder J, Matthews P, Waldmann R. Placebo, prozac and PLoS: significant lessons for psychopharmacology. J Psychopharmacol. 2011;25:1277\u201388. https:\/\/doi.org\/10.1177\/0269881110372544.","journal-title":"J Psychopharmacol"},{"key":"3943_CR106","doi-asserted-by":"crossref","unstructured":"Fountoulakis, KN & Moeller, H Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue. J Psychopharmacol, (in press) (2011).","DOI":"10.1177\/0269881111421969"},{"key":"3943_CR107","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1017\/s1461145711000964","volume":"14","author":"KN Fountoulakis","year":"2011","unstructured":"Fountoulakis KN, M\u00f6ller H-J. Antidepressants vs. placebo: not merely a quantitative difference in response. Int J Neuropsychopharmacol. 2011;14:1435\u20137. https:\/\/doi.org\/10.1017\/s1461145711000964.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3943_CR108","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","volume":"373","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373:746\u201358. https:\/\/doi.org\/10.1016\/S0140-6736(09)60046-5.","journal-title":"Lancet"},{"key":"3943_CR109","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/sj.npp.1300004","volume":"28","author":"CJ Harmer","year":"2003","unstructured":"Harmer CJ, Bhagwagar Z, Perrett DI, Vollm BA, Cowen PJ, Goodwin GM. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology. 2003;28:148\u201352. https:\/\/doi.org\/10.1038\/sj.npp.1300004.","journal-title":"Neuropsychopharmacology"},{"key":"3943_CR110","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1017\/S0007114514003754","volume":"113","author":"MH Mohajeri","year":"2015","unstructured":"Mohajeri MH, Wittwer J, Vargas K, Hogan E, Holmes A, Rogers PJ, et al. Chronic treatment with a tryptophan-rich protein hydrolysate improves emotional processing, mental energy levels and reaction time in middle-aged women. Br J Nutr. 2015;113:350\u201365. https:\/\/doi.org\/10.1017\/S0007114514003754.","journal-title":"Br J Nutr"},{"key":"3943_CR111","doi-asserted-by":"publisher","DOI":"10.1177\/23743735251346666","volume":"12","author":"NN Adams","year":"2025","unstructured":"Adams NN. The Conundrum of Antidepressant-Induced Anhedonia: A Blended Patient-Psychologist Perspective. J Patient Exp. 2025;12:23743735251346666. https:\/\/doi.org\/10.1177\/23743735251346666.","journal-title":"J Patient Exp"},{"key":"3943_CR112","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41386-022-01523-x","volume":"48","author":"C Langley","year":"2023","unstructured":"Langley C, Armand S, Luo Q, Savulich G, Segerberg T, Sondergaard A, et al. Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: A double-blind, placebo-controlled semi-randomised study. Neuropsychopharmacology. 2023;48:664\u201370. https:\/\/doi.org\/10.1038\/s41386-022-01523-x.","journal-title":"Neuropsychopharmacology"},{"key":"3943_CR113","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/wps.20248","volume":"14","author":"P Bech","year":"2015","unstructured":"Bech P. The responsiveness of the different versions of the Hamilton Depression Scale. World Psychiatry. 2015;14:309\u201310. https:\/\/doi.org\/10.1002\/wps.20248.","journal-title":"World Psychiatry"},{"key":"3943_CR114","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/wps.21029","volume":"21","author":"F Hieronymus","year":"2022","unstructured":"Hieronymus F, Lisinski A, Ostergaard SD, Eriksson E. The response pattern to SSRIs as assessed by the Montgomery-Asberg Depression Rating Scale: a patient-level meta-analysis. World Psychiatry. 2022;21:472\u20133. https:\/\/doi.org\/10.1002\/wps.21029.","journal-title":"World Psychiatry"},{"key":"3943_CR115","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/mp.2015.53","volume":"21","author":"F Hieronymus","year":"2016","unstructured":"Hieronymus F, Emilsson JF, Nilsson S, Eriksson E. Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry. 2016;21:523\u201330. https:\/\/doi.org\/10.1038\/mp.2015.53.","journal-title":"Mol Psychiatry"},{"key":"3943_CR116","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-0447.1985.tb02601.x","volume":"72","author":"W Maier","year":"1985","unstructured":"Maier W, Philipp M. Comparative analysis of observer depression scales. Acta Psychiatr Scand. 1985;72:239\u201345. https:\/\/doi.org\/10.1111\/j.1600-0447.1985.tb02601.x.","journal-title":"Acta Psychiatr Scand"},{"key":"3943_CR117","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S0033291709006102","volume":"40","author":"P Bech","year":"2010","unstructured":"Bech P. Is the antidepressive effect of second-generation antidepressants a myth?. Psychological medicine. 2010;40:181\u20136. https:\/\/doi.org\/10.1017\/S0033291709006102.","journal-title":"Psychological medicine"},{"key":"3943_CR118","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1017\/S1461145704004365","volume":"7","author":"P Bech","year":"2004","unstructured":"Bech P, Tanghoj P, Cialdella P, Andersen HF, Pedersen AG. Escitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. Int J Neuropsychopharmacol. 2004;7:283\u201390. https:\/\/doi.org\/10.1017\/S1461145704004365.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3943_CR119","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/JCP.0b013e31825d6c25","volume":"32","author":"G Martinotti","year":"2012","unstructured":"Martinotti G, Sepede G, Gambi F, Di Iorio G, De Berardis D, Di Nicola M, et al. Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study. J Clin Psychopharmacol. 2012;32:487\u201391. https:\/\/doi.org\/10.1097\/JCP.0b013e31825d6c25.","journal-title":"J Clin Psychopharmacol"},{"key":"3943_CR120","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1365-2710.2000.00302.x","volume":"25","author":"P Boyer","year":"2000","unstructured":"Boyer P, Tassin JP, Falissart B, Troy S. Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression. J Clin Pharm Ther. 2000;25:363\u201371. https:\/\/doi.org\/10.1046\/j.1365-2710.2000.00302.x.","journal-title":"J Clin Pharm Ther"},{"key":"3943_CR121","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.biopsych.2011.06.031","volume":"70","author":"SN Light","year":"2011","unstructured":"Light SN, Heller AS, Johnstone T, Kolden GG, Peterson MJ, Kalin NH, Davidson RJ. Reduced right ventrolateral prefrontal cortex activity while inhibiting positive affect is associated with improvement in hedonic capacity after 8 weeks of antidepressant treatment in major depressive disorder. Biol Psychiatry. 2011;70:962\u20138. https:\/\/doi.org\/10.1016\/j.biopsych.2011.06.031.","journal-title":"Biol Psychiatry"},{"key":"3943_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2025.02.897","author":"A Chowdhury","year":"2025","unstructured":"Chowdhury A, Boukezzi S, Costi S, Hameed S, Jacob Y, Salas R, et al. Effects of the KCNQ (Kv7) channel opener ezogabine on resting-state functional connectivity of striatal brain reward regions, depression, and anhedonia in major depressive disorder: Results from a randomized controlled trial. Biol Psychiatry. 2025. https:\/\/doi.org\/10.1016\/j.biopsych.2025.02.897.","journal-title":"Biol Psychiatry"},{"key":"3943_CR123","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1176\/appi.ajp.2020.20050653","volume":"178","author":"S Costi","year":"2021","unstructured":"Costi S, Morris LS, Kirkwood KA, Hoch M, Corniquel M, Vo-Le B, et al. Impact of the KCNQ2\/3 channel opener ezogabine on reward circuit activity and clinical symptoms in depression: results from a randomized controlled trial. Am J Psychiatry. 2021;178:437\u201346. https:\/\/doi.org\/10.1176\/appi.ajp.2020.20050653.","journal-title":"Am J Psychiatry"},{"key":"3943_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-023-00473-y","volume":"22","author":"P Guo","year":"2023","unstructured":"Guo P, Xu Y, Lv L, Feng M, Fang Y, Huang WQ, et al. A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD). Ann Gen Psychiatry. 2023;22:46. https:\/\/doi.org\/10.1186\/s12991-023-00473-y.","journal-title":"Ann Gen Psychiatry"},{"key":"3943_CR125","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/s0165-1781(98)00046-8","volume":"79","author":"R Jouvent","year":"1998","unstructured":"Jouvent R, Le Houezec J, Payan C, Mikkelsen H, Fermanian J, Millet V, Dufour H. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation. Psychiatry Res. 1998;79:267\u201375. https:\/\/doi.org\/10.1016\/s0165-1781(98)00046-8.","journal-title":"Psychiatry Res"},{"key":"3943_CR126","doi-asserted-by":"publisher","first-page":"S492","DOI":"10.1016\/j.euroneuro.2012.07.005","volume":"22","author":"RW Lam","year":"2012","unstructured":"Lam RW. Onset, time course and trajectories of improvement with antidepressants. Eur Neuropsychopharmacol. 2012;22:S492\u2013498. https:\/\/doi.org\/10.1016\/j.euroneuro.2012.07.005.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3943_CR127","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1017\/S1092852924000245","volume":"29","author":"RS McIntyre","year":"2024","unstructured":"McIntyre RS, Agid O, Biesheuvel E, Purushottamahanti P. Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder. CNS Spectr. 2024;29:206\u201314. https:\/\/doi.org\/10.1017\/S1092852924000245.","journal-title":"CNS Spectr"},{"key":"3943_CR128","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2147\/NDT.S296451","volume":"17","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS, Loft H, Christensen MC. Efficacy of vortioxetine on anhedonia: results from a pooled analysis of short-term studies in patients with major depressive disorder. Neuropsychiatr Dis Treat. 2021;17:575\u201385. https:\/\/doi.org\/10.2147\/NDT.S296451.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3943_CR129","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/NDT.S340281","volume":"18","author":"K Watanabe","year":"2022","unstructured":"Watanabe K, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, et al. Therapeutic potential of vortioxetine for anhedonia-like symptoms in depression: A Post Hoc analysis of data from a clinical trial conducted in Japan. Neuropsychiatr Dis Treat. 2022;18:363\u201373. https:\/\/doi.org\/10.2147\/NDT.S340281.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3943_CR130","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00213-020-05737-z","volume":"238","author":"MH Chen","year":"2021","unstructured":"Chen MH, Lin WC, Wu HJ, Bai YM, Li CT, Tsai SJ, et al. Interest-activity symptom severity predicts response to ketamine infusion in treatment-resistant depression. Psychopharmacology (Berl). 2021;238:857\u201365. https:\/\/doi.org\/10.1007\/s00213-020-05737-z.","journal-title":"Psychopharmacology (Berl)"},{"key":"3943_CR131","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1176\/appi.ajp.20230980","volume":"181","author":"EM Hess","year":"2024","unstructured":"Hess EM, Greenstein DK, Hutchinson OL, Zarate CA, Gould TD. Entactogen effects of ketamine: A reverse-translational study. Am J Psychiatry. 2024;181:815\u201323. https:\/\/doi.org\/10.1176\/appi.ajp.20230980.","journal-title":"Am J Psychiatry"},{"key":"3943_CR132","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.euroneuro.2024.04.014","volume":"86","author":"A Kwasny","year":"2024","unstructured":"Kwasny A, Kwasna J, Wilkowska A, Szarmach J, Slupski J, Wlodarczyk A, Cubala WJ. Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review. Eur Neuropsychopharmacol. 2024;86:20\u201334. https:\/\/doi.org\/10.1016\/j.euroneuro.2024.04.014.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3943_CR133","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jad.2021.04.053","volume":"290","author":"R Boden","year":"2021","unstructured":"Boden R, Bengtsson J, Thornblom E, Struckmann W, Persson J. Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression - a randomized controlled trial. J Affect Disord. 2021;290:308\u201315. https:\/\/doi.org\/10.1016\/j.jad.2021.04.053.","journal-title":"J Affect Disord"},{"key":"3943_CR134","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1176\/appi.ajp.20230556","volume":"181","author":"I Dalhuisen","year":"2024","unstructured":"Dalhuisen I, van Oostrom I, Spijker J, Wijnen B, van Exel E, van Mierlo H, et al. rTMS as a next step in antidepressant nonresponders: A randomized comparison with current antidepressant treatment approaches. Am J Psychiatry. 2024;181:806\u201314. https:\/\/doi.org\/10.1176\/appi.ajp.20230556.","journal-title":"Am J Psychiatry"},{"key":"3943_CR135","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jad.2024.01.041","volume":"350","author":"S Kong","year":"2024","unstructured":"Kong S, Chen Y, Huang H, Yang W, Lyu D, Wang F, et al. Efficacy of transcranial direct current stimulation for treating anhedonia in patients with depression: A randomized, double-blind, sham-controlled clinical trial. J Affect Disord. 2024;350:264\u201373. https:\/\/doi.org\/10.1016\/j.jad.2024.01.041.","journal-title":"J Affect Disord"},{"key":"3943_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.119561","volume":"388","author":"X Li","year":"2025","unstructured":"Li X, Man ISC, Shao R, Zhao X, Wu S, Liu Z, Lin K. The effect of non-invasive brain stimulation in reducing anhedonia and apathy in major depressive disorder and schizophrenia: A meta-analysis. J Affect Disord. 2025;388:119561. https:\/\/doi.org\/10.1016\/j.jad.2025.119561.","journal-title":"J Affect Disord"},{"key":"3943_CR137","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jad.2022.08.021","volume":"316","author":"MA Katzman","year":"2022","unstructured":"Katzman MA, Therrien F, MacKenzie EM, Wang F, de Jong-Laird A, Boucher M. Efficacy of adjunctive brexpiprazole on symptom clusters of major depressive disorder: A post hoc analysis of four clinical studies. J Affect Disord. 2022;316:201\u20138. https:\/\/doi.org\/10.1016\/j.jad.2022.08.021.","journal-title":"J Affect Disord"},{"key":"3943_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.05.026","volume":"385","author":"RS McIntyre","year":"2025","unstructured":"McIntyre RS, Maletic V, Masand P, Wilson AC, Yu J, Adams JL, Kerolous M. The effect of adjunctive cariprazine on symptoms of anhedonia in patients with major depressive disorder. J Affect Disord. 2025;385:119366. https:\/\/doi.org\/10.1016\/j.jad.2025.05.026.","journal-title":"J Affect Disord"},{"key":"3943_CR139","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1176\/appi.prcp.20210042","volume":"4","author":"F Ventorp","year":"2022","unstructured":"Ventorp F, Lindahl J, van Westen D, Jensen J, Bjorkstrand J, Lindqvist D. Preliminary evidence of efficacy and target engagement of pramipexole in anhedonic depression. Psychiatr Res Clin Pract. 2022;4:42\u201347. https:\/\/doi.org\/10.1176\/appi.prcp.20210042.","journal-title":"Psychiatr Res Clin Pract"},{"key":"3943_CR140","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jpsychires.2020.06.012","volume":"130","author":"EE Acevedo-Diaz","year":"2020","unstructured":"Acevedo-Diaz EE, Cavanaugh GW, Greenstein D, Kraus C, Kadriu B, Park L, Zarate CA Jr. Can \u2018floating\u2019 predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression. J Psychiatr Res. 2020;130:280\u20135. https:\/\/doi.org\/10.1016\/j.jpsychires.2020.06.012.","journal-title":"J Psychiatr Res"},{"key":"3943_CR141","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ijlp.2008.09.001","volume":"31","author":"DR Waring","year":"2008","unstructured":"Waring DR. The antidepressant debate and the balanced placebo trial design: an ethical analysis. Int J Law Psychiatry. 2008;31:453\u201362. https:\/\/doi.org\/10.1016\/j.ijlp.2008.09.001.","journal-title":"Int J Law Psychiatry"},{"key":"3943_CR142","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/bmj.331.7509.155","volume":"331","author":"J Moncrieff","year":"2005","unstructured":"Moncrieff J, Kirsch I. Efficacy of antidepressants in adults. BMJ. 2005;331:155\u20137. https:\/\/doi.org\/10.1136\/bmj.331.7509.155.","journal-title":"BMJ"},{"key":"3943_CR143","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1176\/appi.ajp.159.2.191","volume":"159","author":"MA Posternak","year":"2002","unstructured":"Posternak MA, Zimmerman M, Keitner GI, Miller IW. A reevaluation of the exclusion criteria used in antidepressant efficacy trials. Am J Psychiatry. 2002;159:191\u2013200. https:\/\/doi.org\/10.1176\/appi.ajp.159.2.191.","journal-title":"Am J Psychiatry"},{"key":"3943_CR144","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/npp.1994.63","volume":"11","author":"MH Trivedi","year":"1994","unstructured":"Trivedi MH, Rush H. Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?. Neuropsychopharmacology. 1994;11:33\u201343. https:\/\/doi.org\/10.1038\/npp.1994.63.","journal-title":"Neuropsychopharmacology"},{"key":"3943_CR145","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/bmj.39524.439618.25","volume":"336","author":"TJ Kaptchuk","year":"2008","unstructured":"Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ. 2008;336:999\u20131003. https:\/\/doi.org\/10.1136\/bmj.39524.439618.25.","journal-title":"BMJ"},{"key":"3943_CR146","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cpr.2009.09.003","volume":"30","author":"P Cuijpers","year":"2010","unstructured":"Cuijpers P, van Straten A, Schuurmans J, van Oppen P, Hollon SD, Andersson G. Psychotherapy for chronic major depression and dysthymia: a meta-analysis. Clin Psychol Rev. 2010;30:51\u201362. https:\/\/doi.org\/10.1016\/j.cpr.2009.09.003.","journal-title":"Clin Psychol Rev"},{"key":"3943_CR147","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1192\/bjp.bp.109.066001","volume":"196","author":"P Cuijpers","year":"2010","unstructured":"Cuijpers P, Smit F, Bohlmeijer E, Hollon SD, Andersson G. Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. Br J Psychiatry. 2010;196:173\u20138. https:\/\/doi.org\/10.1192\/bjp.bp.109.066001.","journal-title":"Br J Psychiatry"},{"key":"3943_CR148","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1177\/0269881111421969","volume":"26","author":"KN Fountoulakis","year":"2012","unstructured":"Fountoulakis KN, Moller HJ. Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue. J Psychopharmacol. 2012;26:744\u201350. https:\/\/doi.org\/10.1177\/0269881111421969.","journal-title":"J Psychopharmacol"},{"key":"3943_CR149","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1136\/bmj.308.6942.1499","volume":"308","author":"J Bland","year":"1994","unstructured":"Bland J, Altman D. Regression towards the mean. BMJ. 1994;308:1499.","journal-title":"BMJ"},{"key":"3943_CR150","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/bmj.309.6957.780","volume":"309","author":"J Bland","year":"1994","unstructured":"Bland J, Altman D. Some examples of regression towards the mean. BMJ. 1994;309:780.","journal-title":"BMJ"},{"key":"3943_CR151","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00005053-196304000-00009","volume":"136","author":"S Gelfand","year":"1963","unstructured":"Gelfand S, Ullmann LP, Krasner L. The placebo response: an experimental approach. J Nerv Ment Dis. 1963;136:379\u201387. https:\/\/doi.org\/10.1097\/00005053-196304000-00009.","journal-title":"J Nerv Ment Dis"},{"key":"3943_CR152","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jpsychores.2007.11.007","volume":"64","author":"B Whalley","year":"2008","unstructured":"Whalley B, Hyland ME, Kirsch I. Consistency of the placebo effect. J Psychosom Res. 2008;64:537\u201341. https:\/\/doi.org\/10.1016\/j.jpsychores.2007.11.007.","journal-title":"J Psychosom Res"},{"key":"3943_CR153","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/jclp.20126","volume":"61","author":"I Kirsch","year":"2005","unstructured":"Kirsch I. Placebo psychotherapy: synonym or oxymoron?. J Clin Psychol. 2005;61:791\u2013803. https:\/\/doi.org\/10.1002\/jclp.20126.","journal-title":"J Clin Psychol"},{"key":"3943_CR154","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1037\/0033-2909.130.2.341","volume":"130","author":"I Kirsch","year":"2004","unstructured":"Kirsch I. Conditioning, expectancy, and the placebo effect: comment on Stewart-Williams and Podd (2004). Psychol Bull. 2004;130:341\u20133. https:\/\/doi.org\/10.1037\/0033-2909.130.2.341. discussion 344-345.","journal-title":"Psychol Bull"},{"key":"3943_CR155","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.39520.483565.3A","volume":"336","author":"I Kirsch","year":"2008","unstructured":"Kirsch I, Johnson BT. Moving beyond depression: How full is the glass?. BMJ. 2008;336:629\u201330. https:\/\/doi.org\/10.1136\/bmj.39520.483565.3A.","journal-title":"BMJ"},{"key":"3943_CR156","doi-asserted-by":"crossref","first-page":"359","DOI":"10.12968\/hmed.2008.69.6.29632","volume":"69","author":"I Kirsch","year":"2008","unstructured":"Kirsch I. Antidepressant drugs \u2018work\u2019, but they are not clinically effective. Br J Hosp Med (Lond). 2008;69:359.","journal-title":"Br J Hosp Med (Lond)"},{"key":"3943_CR157","first-page":"219","volume":"11","author":"I Kirsch","year":"2008","unstructured":"Kirsch I. Challenging received wisdom: antidepressants and the placebo effect. Mcgill J Med. 2008;11:219\u201322.","journal-title":"Mcgill J Med"},{"key":"3943_CR158","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cct.2006.10.012","volume":"28","author":"I Kirsch","year":"2007","unstructured":"Kirsch I, Moncrieff J. Clinical trials and the response rate illusion. Contemp Clin Trials. 2007;28:348\u201351. https:\/\/doi.org\/10.1016\/j.cct.2006.10.012.","journal-title":"Contemp Clin Trials"},{"key":"3943_CR159","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/acps.12275","volume":"130","author":"TA Furukawa","year":"2014","unstructured":"Furukawa TA, Noma H, Caldwell DM, Honyashiki M, Shinohara K, Imai H, et al. Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatr Scand. 2014;130:181\u201392. https:\/\/doi.org\/10.1111\/acps.12275.","journal-title":"Acta Psychiatr Scand"},{"key":"3943_CR160","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3389\/fpsyt.2019.00555","volume":"10","author":"C Locher","year":"2019","unstructured":"Locher C, Koechlin H, Gaab J, Gerger H. The Other Side of the Coin: Nocebo Effects and Psychotherapy. Front Psychiatry. 2019;10:555. https:\/\/doi.org\/10.3389\/fpsyt.2019.00555.","journal-title":"Front Psychiatry"},{"key":"3943_CR161","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1017\/S2045796018000665","volume":"28","author":"IA Cristea","year":"2019","unstructured":"Cristea IA. The waiting list is an inadequate benchmark for estimating the effectiveness of psychotherapy for depression. Epidemiol Psychiatr Sci. 2019;28:278\u20139. https:\/\/doi.org\/10.1017\/S2045796018000665.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"3943_CR162","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1056\/NEJMra1907805","volume":"382","author":"L Colloca","year":"2020","unstructured":"Colloca L, Barsky AJ. Placebo and nocebo effects. N Engl J Med. 2020;382:554\u201361. https:\/\/doi.org\/10.1056\/NEJMra1907805.","journal-title":"N Engl J Med"},{"key":"3943_CR163","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jad.2006.06.015","volume":"97","author":"KN Fountoulakis","year":"2007","unstructured":"Fountoulakis KN, Bech P, Panagiotidis P, Siamouli M, Kantartzis S, Papadopoulou A, et al. Comparison of depressive indices: reliability, validity, relationship to anxiety and personality and the role of age and life events. J Affect Disord. 2007;97:187\u201395. https:\/\/doi.org\/10.1016\/j.jad.2006.06.015.","journal-title":"J Affect Disord"},{"key":"3943_CR164","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/wps.21069","volume":"22","author":"P Cuijpers","year":"2023","unstructured":"Cuijpers P, Miguel C, Harrer M, Plessen CY, Ciharova M, Ebert D, Karyotaki E. Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: A comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry. 2023;22:105\u201315. https:\/\/doi.org\/10.1002\/wps.21069.","journal-title":"World Psychiatry"},{"key":"3943_CR165","doi-asserted-by":"crossref","unstructured":"Wampold, BE, Mondin, GW, Moody, M, Stich, F, Benson, K & Ahn, H-NJPB A meta-analysis of outcome studies comparing bona fide psychotherapies: Empiricially,\u201d all must have prizes.\u201d. 1997;122,203.","DOI":"10.1037\/0033-2909.122.3.203"},{"key":"3943_CR166","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/wps.20860","volume":"20","author":"P Cuijpers","year":"2021","unstructured":"Cuijpers P, Quero S, Noma H, Ciharova M, Miguel C, Karyotaki E, et al. Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types. World Psychiatry. 2021;20:283\u201393. https:\/\/doi.org\/10.1002\/wps.20860.","journal-title":"World Psychiatry"},{"key":"3943_CR167","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1017\/s0813483900007592","volume":"6","author":"G Clarke","year":"2014","unstructured":"Clarke G, Lewinsohn PM. The coping with depression course: A group psychoeducational intervention for unipolar depression. Behaviour Change. 2014;6:54\u201369. https:\/\/doi.org\/10.1017\/s0813483900007592.","journal-title":"Behaviour Change"},{"key":"3943_CR168","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/10503307.2019.1649732","volume":"30","author":"P Cuijpers","year":"2020","unstructured":"Cuijpers P, Karyotaki E, de Wit L, Ebert DD. The effects of fifteen evidence-supported therapies for adult depression: A meta-analytic review. Psychother Res. 2020;30:279\u201393. https:\/\/doi.org\/10.1080\/10503307.2019.1649732.","journal-title":"Psychother Res"},{"key":"3943_CR169","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/10503307.2022.2138792","volume":"33","author":"P Cuijpers","year":"2023","unstructured":"Cuijpers P. The Dodo Bird and the need for scalable interventions in global mental health-A commentary on the 25th anniversary of Wampold et al. (1997). Psychother Res. 2023;33:524\u20136. https:\/\/doi.org\/10.1080\/10503307.2022.2138792.","journal-title":"Psychother Res"},{"key":"3943_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2013.02.030","volume":"149","author":"P Cuijpers","year":"2013","unstructured":"Cuijpers P, Huibers M, Ebert DD, Koole SL, Andersson G. How much psychotherapy is needed to treat depression? A metaregression analysis. J Affect Disord. 2013;149:1\u201313. https:\/\/doi.org\/10.1016\/j.jad.2013.02.030.","journal-title":"J Affect Disord"},{"key":"3943_CR171","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1192\/j.eurpsy.2023.2437","volume":"66","author":"P Cuijpers","year":"2023","unstructured":"Cuijpers P, Miguel C, Harrer M, Ciharova M, Karyotaki E. Does the use of pharmacotherapy interact with the effects of psychotherapy? A meta-analytic review. Eur Psychiatry. 2023;66:e63 https:\/\/doi.org\/10.1192\/j.eurpsy.2023.2437.","journal-title":"Eur Psychiatry"},{"key":"3943_CR172","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jad.2023.05.011","volume":"335","author":"P Cuijpers","year":"2023","unstructured":"Cuijpers P, Miguel C, Harrer M, Plessen CY, Ciharova M, Papola D, et al. Psychological treatment of depression: A systematic overview of a \u2018Meta-Analytic Research Domain\u2019. J Affect Disord. 2023;335:141\u201351. https:\/\/doi.org\/10.1016\/j.jad.2023.05.011.","journal-title":"J Affect Disord"},{"key":"3943_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-015-0063-1","volume":"14","author":"E Dragioti","year":"2015","unstructured":"Dragioti E, Dimoliatis I, Fountoulakis KN, Evangelou E. A systematic appraisal of allegiance effect in randomized controlled trials of psychotherapy. Ann Gen Psychiatry. 2015;14:25. https:\/\/doi.org\/10.1186\/s12991-015-0063-1.","journal-title":"Ann Gen Psychiatry"},{"key":"3943_CR174","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"JJ Schildkraut","year":"1965","unstructured":"Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965;122:509\u201322. https:\/\/doi.org\/10.1176\/ajp.122.5.509.","journal-title":"Am J Psychiatry"},{"key":"3943_CR175","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/archpsyc.1975.01760290025002","volume":"32","author":"JW Maas","year":"1975","unstructured":"Maas JW. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry. 1975;32:1357\u201361. https:\/\/doi.org\/10.1001\/archpsyc.1975.01760290025002.","journal-title":"Arch Gen Psychiatry"},{"key":"3943_CR176","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF00413327","volume":"4","author":"M Van Praag","year":"1963","unstructured":"Van Praag M, Leijnse B. Die Bedeutung Dermonoamineoxydashemmung als Antidepressives Prinzip I. Psychopharmacologia. 1963;4:91\u2013102.","journal-title":"Psychopharmacologia"},{"key":"3943_CR177","first-page":"203","volume":"4","author":"JJ Schildkraut","year":"1967","unstructured":"Schildkraut JJ. The catecholamine hypothesis of affective disorders. A review of supporting evidence. Int J Psychiatry. 1967;4:203\u201317.","journal-title":"Int J Psychiatry"},{"key":"3943_CR178","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s41562-023-01609-6","volume":"7","author":"FA Hagenbeek","year":"2023","unstructured":"Hagenbeek FA, Hirzinger JS, Breunig S, Bruins S, Kuznetsov DV, Schut K, et al. Maximizing the value of twin studies in health and behaviour. Nat Hum Behav. 2023;7:849\u201360. https:\/\/doi.org\/10.1038\/s41562-023-01609-6.","journal-title":"Nat Hum Behav"},{"key":"3943_CR179","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1017\/neu.2018.24","volume":"31","author":"KN Fountoulakis","year":"2019","unstructured":"Fountoulakis KN, Souliotis K. The right to choose treatment-without-treatment: respecting civil rights or an unprecedented manifestation of \u2018reverse stigma\u2019?. Acta Neuropsychiatr. 2019;31:56\u201358. https:\/\/doi.org\/10.1017\/neu.2018.24.","journal-title":"Acta Neuropsychiatr"},{"key":"3943_CR180","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/ACM.0b013e31819a8052","volume":"84","author":"CF Reynolds 3rd","year":"2009","unstructured":"Reynolds CF 3rd, Lewis DA, Detre T, Schatzberg AF, Kupfer DJ. The future of psychiatry as clinical neuroscience. Acad Med. 2009;84:446\u201350. https:\/\/doi.org\/10.1097\/ACM.0b013e31819a8052.","journal-title":"Acad Med"},{"key":"3943_CR181","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/psyp.12342","volume":"51","author":"BN Cuthbert","year":"2014","unstructured":"Cuthbert BN. Translating intermediate phenotypes to psychopathology: the NIMH Research Domain Criteria. Psychophysiology. 2014;51:1205\u20136. https:\/\/doi.org\/10.1111\/psyp.12342.","journal-title":"Psychophysiology"},{"key":"3943_CR182","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/wps.20087","volume":"13","author":"BN Cuthbert","year":"2014","unstructured":"Cuthbert BN. The RDoC framework: facilitating transition from ICD\/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry. 2014;13:28\u201335. https:\/\/doi.org\/10.1002\/wps.20087.","journal-title":"World Psychiatry"},{"key":"3943_CR183","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jamapsychiatry.2014.3199","volume":"72","author":"DA Ross","year":"2015","unstructured":"Ross DA, Travis MJ, Arbuckle MR. The future of psychiatry as clinical neuroscience: why not now?. JAMA Psychiatry. 2015;72:413\u20134. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.3199.","journal-title":"JAMA Psychiatry"},{"key":"3943_CR184","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s40596-014-0065-3","volume":"38","author":"M Akil","year":"2014","unstructured":"Akil M, Etkin A. Transforming neuroscience education in psychiatry. Acad Psychiatry. 2014;38:116\u201320. https:\/\/doi.org\/10.1007\/s40596-014-0065-3.","journal-title":"Acad Psychiatry"},{"key":"3943_CR185","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s40596-014-0055-5","volume":"38","author":"DA Ross","year":"2014","unstructured":"Ross DA, Rohrbaugh R. Integrating neuroscience in the training of psychiatrists: a patient-centered didactic curriculum based on adult learning principles. Acad Psychiatry. 2014;38:154\u201362. https:\/\/doi.org\/10.1007\/s40596-014-0055-5.","journal-title":"Acad Psychiatry"},{"key":"3943_CR186","unstructured":"Askay R & Farquhar-Lacewing, J in The Oxford Handbook of Philosophy and Psychiatry (eds KWM Fulford et al.) (Oxford University Press, 2013)."},{"key":"3943_CR187","unstructured":"Lacewing M in The Oxford Handbook of Philosophy and Psychiatry (eds KWM Fulford et al.) (Oxford University Press, 2013)."},{"key":"3943_CR188","unstructured":"Hopkins J in The Oxford Handbook of Philosophy and Psychiatry (eds KWM Fulford et al.) (Oxford University Press, 2013)."},{"key":"3943_CR189","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/wps.20151","volume":"13","author":"G Andersson","year":"2014","unstructured":"Andersson G, Cuijpers P, Carlbring P, Riper H, Hedman E. Guided Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: A systematic review and meta-analysis. World Psychiatry. 2014;13:288\u201395. https:\/\/doi.org\/10.1002\/wps.20151.","journal-title":"World Psychiatry"},{"key":"3943_CR190","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.brat.2015.08.010","volume":"74","author":"N Morina","year":"2015","unstructured":"Morina N, Ijntema H, Meyerbroker K, Emmelkamp PM. Can virtual reality exposure therapy gains be generalized to real-life? A meta-analysis of studies applying behavioral assessments. Behav Res Ther. 2015;74:18\u201324. https:\/\/doi.org\/10.1016\/j.brat.2015.08.010.","journal-title":"Behav Res Ther"},{"key":"3943_CR191","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.2196\/mental.7785","volume":"4","author":"KK Fitzpatrick","year":"2017","unstructured":"Fitzpatrick KK, Darcy A, Vierhile M. Delivering cognitive behavior therapy to young adults with symptoms of depression and anxiety using a fully automated conversational agent (Woebot): A randomized controlled trial. JMIR Ment Health. 2017;4:e19. https:\/\/doi.org\/10.2196\/mental.7785.","journal-title":"JMIR Ment Health"},{"key":"3943_CR192","doi-asserted-by":"crossref","unstructured":"Fulford KWM, Thornton T, Graham G (eds). Knowledge, research and evidence-based medicine. In: The Oxford Textbook of Philosophy and Psychiatry, Ch. 16, pp. 433\u2013464 (Oxford University Press, 2006).","DOI":"10.1093\/oso\/9780198526940.003.0016"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03943-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03943-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03943-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:25:06Z","timestamp":1774967106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03943-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":192,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3943"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03943-5","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KNF has received honoraria for lectures or support to attend conferences from AstraZeneca, Janssen-Cilag, Eli-Lilly, and research grants from AstraZeneca, and the Pfizer Foundation, but for the last 5 years has no such interaction and is free of conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}